Interview with Marko Dolzan, President, Polfa Lodz
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
Address: ul. Drewnowska 43/55, 91-002 Lodz
Tel: +48 42 654 00 70
Web: http://www.polfa-lodz.com/
For 75 years, we have been specialising in producing top quality medicinal products, dietary supplements and cosmetics. Thanks to the trust of physicians and pharmacists, our products can be found in every Polish home.
Our strongest desire is to perfect our preparations and to make efforts to increase their safety and efficacy. We are constantly striving to maintain the highest production standards – our production processes comply with GMP, HACCP and ISO standards.
In order to maintain continuous development, we merged with SENSILAB Sp. z o.o. in 2008.
We are one of the leading drugs and dietary supplements manufacturers in Poland. Every year over 5,000,000 packets of our products are shipped to our customers. We offer over 50 different preparations. We are a leading manufacturer of calcium preparations based on the most easily absorbable form of calcium.
We are a pharmaceutical manufacturer which – apart from producing its own preparations – also provides contracted production services. Depending on the demand, our R&D department can develop products to be manufactured under a customer’s brand name. Owing to our modern and highly efficient equipment, we can fulfil your orders promptly. We take production services for our partners very seriously. We treat every enquiry on an individual basis, which results in the comprehensive service that our company can offer.
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
Stefan Buguslawski, president of PEX Pharmasequence, a leading Polish healthcare consultancy and market research company, highlights the current obstacles facing the Polish healthcare market and the dynamics of the domestic…
Piotr Ponikowski, president of the Polish Cardiac Society, discusses the positive steps Poland is taking to construct an effective program against cardiovascular disease as well as the importance of a…
Wojciech Sulimierski, general manager of Aspen Poland and CEE, discusses the opening of the regional operations in 2014 and the importance of the CEE region as the company establishes itself…
Jarek Oleszczuk, country president of AstraZeneca Poland, the leading R&D investor in Poland, discusses the exciting milestones that the company has achieved, including reimbursement of two breakthrough oncology therapies, as…
Drago Vuina, corporate vice-president of Novo Nordisk Eastern Europe, highlights Poland as the most significant market in the region and the on-going commitment to make innovative treatment options available for…
Jakub Szulc, director of life sciences at EY Poland, discusses the exciting opportunities that exist within the healthcare sector in the flourishing Polish economy and the overriding need to increase…
Samantha Kingdom, general manager of Amgen Poland, highlights her strategy to be a significant contributor within the Polish healthcare space, while delivering highly innovative products to significantly improve Polish patients’…
Jacek Mazurkiewicz, general manager of AbbVie Poland, discusses the recent exciting achievements of the affiliate, including the reimbursement of its products in recent years and the set up one of…
Maciej Kuźmierkiewicz, general manager of IQVIA Poland and the Baltics, discusses the implications of global changes on the Polish affiliate (which now employs 1000 staff) and the challenges of promoting…
Wojciech Koziejowski, managing director of Lundbeck Poland, discusses attaining reimbursement in Poland for the first time in ten years and the recent set-up of their global shared service center of…
Denis Vujičić, managing director of MSD Poland, discusses his overriding mission to give Polish patients greater access to breakthrough therapies and highlights the affiliate’s extensive R&D capabilities that entail both…
Irena Rej, president of the Polish Pharmaceutical Chamber, Farmacja Polska, discusses the trends of the domestic pharmaceutical market and the recent changes to improve the introduction of innovative products. Furthermore,…
See our Cookie Privacy Policy Here